Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
AQST
CBIO
Add up to 3 more stocks
AQST
Aquestive Therapeutics, Inc.
-0.27%
$4.56-0.01Delayed quote: Oct 6, 2026, 12:50 PM EDT
Market Cap
$571.83M
52W Range
$2.93 - $7.55
CBIO
Crescent Biopharma, Inc.
-1.08%
$13.79-0.15Delayed quote: Oct 6, 2026, 12:49 PM EDT
Market Cap
$512.21M
52W Range
$8.72 - $27.41
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | N/A | 3.22 |
| P/S Ratio | 10.57 | 43.10 |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 67.0% | 100.0% |
| Operating Margin | -156.4% | -1407.5% |
| Net Margin | -144.6% | -1371.5% |
| ROE | N/A | -99.8% |
| ROA | -59.2% | -89.2% |
| ROIC | -45.6% | -102.6% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 7.19 | 9.66 |
| Quick Ratio | 6.74 | 9.66 |
| Debt/Equity | N/A | 0.01 |
| Interest Coverage | -4.07 | -69.85 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.